Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | NGLFINE NGL Fine-Chem Limited Pharma · Small | INDSWFTLAB Ind-Swift Laboratories Limited Pharma · Small | ARVEE Arvee Laboratories (India) Limited Pharma · Small | LASA Lasa Supergenerics Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 34 | 39 | 21 | 5 |
| Verdict | WATCHLIST | WATCHLIST | OVERVALUED | OVERVALUED |
| Style | WATCHLIST | WATCHLIST | OVERVALUED | Distress Watch |
| Piotroski | 8/9 | 4/9 | 5/9 | 2/9 |
| Valuation | 0/30 | 7/30 | 0/30 | 5/30 |
| Growth | 6/25 | 17/25 | 11/25 | 0/25 |
| Quality | 11/20 | 0/20 | 0/20 | 0/20 |
| Balance Sheet | 10/15 | 12/15 | 11/15 | 5/15 |
| Cash Flow | 3/10 | 3/10 | 3/10 | 3/10 |
| Price | ₹2,820.7 | ₹161.87 | ₹163.57 | ₹7.61 |
| P/E | 36.00 | 28.30 | 69.60 | — |
| P/B | 5.29 | 1.02 | 5.21 | 0.78 |
| ROE | 15.70% | 3.87% | 7.78% | -19.60% |
| ROCE | 17.00% | 4.70% | 7.92% | -18.20% |
| Debt / Equity | 0.33 | 0.01 | 0.03 | 0.20 |
| FCF Yield | — | — | 0.22% | — |
| Dividend Y | 0.06% | — | — | — |
| Altman Z | 7.20 | 4.76 | 7.99 | 1.73 |
| Promoter % | 72.73% | 43.00% | 73.50% | 53.65% |
| Mkt Cap (₹Cr) | 1732.00 | 1401.00 | 176.00 | 38.20 |
| Graham # | ₹966.61 | ₹130.63 | ₹39.86 | — |
| Fair PE | 6.2 | 42.0 | 42.0 | 1.3 |
| MoS % | -482.0% | +19.2% | -69.3% | — |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startNGLFINE138
INDSWFTLAB144
ARVEE96
LASA27